Active, not recruitingNCT06184971
Biliary Atresia Research Network Northeast
Studying Isolated biliary atresia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yale University
- Principal Investigator
- Robert Cowles, MDYale University
- Enrollment
- 150 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2024 – 2025
Study locations (14)
- Connecticut Children's Medical Center, Hartford, Connecticut, United States
- Yale University, New Haven, Connecticut, United States
- Eastern Maine Medical Center, Bangor, Maine, United States
- Maine Medical Center, Portland, Maine, United States
- Massachusetts General Hospital for Children, Boston, Massachusetts, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Baystate, Springfield, Massachusetts, United States
- UMass Memorial Medical Center, Worcester, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
- Albany Medical Center/Bernard & Millie Duke's Children's Hospital, Albany, New York, United States
- John R. Oishei Children's Hospital, Buffalo, New York, United States
- University of Rochester Medical Center/Golisano Children's Hospital, Rochester, New York, United States
- SUNY Upstate Medical University, Syracuse, New York, United States
- Rhode Island Hospital/Hasbro Children's Hospital, Providence, Rhode Island, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06184971 on ClinicalTrials.govOther trials for Isolated biliary atresia
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07250854The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal CholestasisUniversity of Alabama at Birmingham
- RECRUITINGNANCT06764082Nutritional Intervention for Biliary AtresiaTongji Hospital
- RECRUITINGNANCT06564740Stem Cell Applications in Biliary Atresia PatientsNecmi Kadıoğlu Hospital
- RECRUITINGNCT05848310Preoperative Serum FGF19 in the Prognosis of Biliary AtresiaChildren's Hospital of Fudan University
- RECRUITINGNANCT05925309Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai PortoenterostomyChildren's Hospital of Fudan University
- ENROLLING BY INVITATIONPHASE3NCT05426733An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary AtresiaAlbireo, an Ipsen Company
- RECRUITINGNCT05072626High Medium-chain Triglyceride Nutritional Support in Infants With Biliary AtresiaChildren's Hospital of Fudan University
- RECRUITINGNANCT04272515Molecular Characterization for Understanding Biliary AtresiaInstitut National de la Santé Et de la Recherche Médicale, France